Clinical Trials

Amivantamab Injection Eradicates Tumours in Treatment‑Resistant Head and Neck Cancer Trial

ICR’s OrigAMI‑4 cohort showed rapid tumour responses with generally manageable side effects, offering a potential new option for patients who have exhausted chemo or immunotherapy.